Early experience with the Impella pump: Single-center registry.
Alina ZubarevichArian Arjomandi RadMarcin SzczechowiczPeter LuedikeAchim KochNikolaus PizanisMarkus KamlerArjang RuhparwarAlexander WeymannBastian SchmackPublished in: Artificial organs (2022)
The Impella® axial-flow pump seems an appropriate therapeutic option for patients with acute cardiogenic shock requiring partial or full hemodynamic support. It also provides sufficient left ventricular unloading to allow full mobilization and neurological assessment of the patients. Furthermore, Impella® offers a high rate of myocardial recovery.
Keyphrases
- left ventricular
- end stage renal disease
- extracorporeal membrane oxygenation
- ejection fraction
- chronic kidney disease
- left ventricular assist device
- newly diagnosed
- heart failure
- aortic stenosis
- acute myocardial infarction
- hypertrophic cardiomyopathy
- patient reported outcomes
- acute coronary syndrome
- cardiac resynchronization therapy
- patient reported
- aortic valve
- brain injury
- subarachnoid hemorrhage